Domů › Nemalobuněčný plicní karcinom › Florida › Miami
Klinické studie Nemalobuněčný plicní karcinom v Miami, FL
31 studií pro Nemalobuněčný plicní karcinom hledá účastníky v lokalitách v Miami a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Probíhá náborFáze 3
- Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Probíhá náborFáze 1
- Exelixis Clinical Site #47, Miami
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Probíhá náborFáze 3
- Miami Cancer Institute, Miami
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Probíhá náborFáze 3
- Sylvester Comprehensive Cancer Center Miami, Miami
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- Sylvester Comprehensive Cancer Center, Miami
- Baptist Health Miami Cancer Institute, Miami
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- University of Miami, Miami
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Probíhá náborFáze 1/2
- Miami Cancer Institute, Miami
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Probíhá náborFáze 3
- Local Institution - 0696, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Probíhá náborFáze 1
- Sylvester Comprehensive Cancer Center, Miami
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Probíhá náborFáze 1/2
- Sylvester Comprehensive Cancer Center - Miami, Miami
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Probíhá náborFáze 1
- Biogenix Molecular, LLC, Miami
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Probíhá náborFáze 2/3
- Miami Veterans Affairs Healthcare System, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- University of Miami, Miami
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Sylvester Comprehensive Cancer Center, Miami
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- University of Miami, Miami
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Probíhá náborFáze 3
- Miami Cancer Institute at Baptist Health, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Probíhá náborFáze 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Probíhá náborFáze 2
- University of Miami, Miami
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Probíhá náborFáze 1/2
- Sylvester Comprehensive Cancer Center, Miami
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Probíhá náborFáze 2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Bioresearch Partner, Miami
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
A Study of VET3-TGI in Patients With Solid Tumors
Probíhá náborFáze 1
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Probíhá náborFáze 2
- Baptist Alliance - McI, Miami
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Probíhá nábor
- Miami VA Healthcare System, Miami, FL, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Miami
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Probíhá náborObservační studie
- Baptist Health South Florida, Miami
Studie Nemalobuněčný plicní karcinom v jiných městech
- Houston, TX145 studií
- New York City, NY120 studií
- Arlington, VA104 studií
- Nashville, TN97 studií
- Boston, MA90 studií
- Los Angeles, CA87 studií
- St. Louis, MO73 studií
- Chicago, IL61 studií
- Baltimore, MD60 studií
- San Antonio, TX59 studií
- Columbus, OH56 studií
- Washington, DC55 studií
Další studie v Miami
- Rakovina prsu42 studií
- Rakovina (všechny typy)36 studií
- Rakovina prostaty27 studií
- Obesity27 studií
- Akutní myeloidní leukemie24 studií
- Metastatický karcinom24 studií
- Rakovina vaječníků23 studií
- Nadváha23 studií
- Mnohočetný myelom21 studií
- Ulcerózní kolitida21 studií
- Alzheimerova choroba20 studií
- Rakovina plic20 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.